{"transactions":[{"id":1787199,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-09-06T22:24:56.000Z","date":"2023-09-04","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates."}],"balance_after":15000,"derivative":{"exercise_price":0.67,"expiration_date":"2033-09-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-23-074480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390023074480/ownership.xml","form_type":"4"}},{"id":1787198,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-06T22:24:56.000Z","date":"2023-09-04","kind":"grant","planned":false,"acquired":true,"shares":22388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."}],"balance_after":34857.019,"source":{"system":"sec-edgar","filing":"0001213900-23-074480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390023074480/ownership.xml","form_type":"4"}},{"id":1884673,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T12:45:13.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":7082.019,"price":1.06,"value":7506.94014,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.03 to $1.07, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":12469.019,"source":{"system":"sec-edgar","filing":"0001213900-23-041331","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390023041331/ownership.xml","form_type":"4"}},{"id":2127187,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-02T21:02:11.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":32037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended September 30, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended September 30, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."}],"balance_after":60170,"source":{"system":"sec-edgar","filing":"0001213900-22-068722","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390022068722/ownership.xml","form_type":"4"}},{"id":2200288,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-29T20:18:29.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":13636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended June 30, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended June 30, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."}],"balance_after":28133,"source":{"system":"sec-edgar","filing":"0001213900-22-042961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390022042961/ownership.xml","form_type":"4"}},{"id":2207483,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"disposition_to_issuer","acquired":false,"shares":84000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This option, which provided for vesting over a period of four years with 1/4th of the shares subject to the option vesting twelve months after the vesting commencement date of September 27, 2013, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, was assumed by BIOX in the Merger and replaced with an option to purchase 7,392 Ordinary Shares of BIOX for $204.66 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"This option, which provided for vesting over a period of four years with 1/4th of the shares subject to the option vesting twelve months after the vesting commencement date of September 27, 2013, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, was assumed by BIOX in the Merger and replaced with an option to purchase 7,392 Ordinary Shares of BIOX for $204.66 per share."}],"balance_after":0,"derivative":{"exercise_price":18.01,"expiration_date":"2023-09-27","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2207482,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"disposition_to_issuer","acquired":false,"shares":482,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This option, which provided for vesting with respect to 1/4th of the total shares subject to the option on October 29, 2013, and 1/48th of the total shares subject to the option monthly thereafter for 36 months, was assumed by BIOX in the Merger and replaced with an option to purchase 5,607 Ordinary Shares of BIOX for $137.31 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option, which provided for vesting over a period of four years, with 1/4th of the shares subject to the option vesting twelve months after the vesting commencement date of November 6, 2013, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, was assumed by BIOX in the Merger and replaced with an option to purchase 42 Ordinary Shares of BIOX for $190.57  per share."}],"balance_after":0,"derivative":{"exercise_price":16.77,"expiration_date":"2023-11-06","underlying":"Common Stock","underlying_shares":482},"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2207481,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"disposition_to_issuer","acquired":false,"shares":63725,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This option, which provided for vesting over a period of four years, with 1/4th of the shares subject to the option vesting twelve months after the vesting commencement date of August 1, 2013, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, was assumed by BIOX in the Merger and replaced with an option to purchase 168 Ordinary Shares of BIOX for $136.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"This option, which provided for vesting with respect to 1/4th of the total shares subject to the option on October 29, 2013, and 1/48th of the total shares subject to the option monthly thereafter for 36 months, was assumed by BIOX in the Merger and replaced with an option to purchase 5,607 Ordinary Shares of BIOX for $137.31 per share."}],"balance_after":0,"derivative":{"exercise_price":12.08,"expiration_date":"2023-10-29","underlying":"Common Stock","underlying_shares":63725},"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2207480,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"disposition_to_issuer","acquired":false,"shares":1911,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This option, which provided for vesting over a period of four years, with 1/4th of the shares subject to the option vesting twelve months after the vesting commencement date of August 1, 2013, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, was assumed by BIOX in the Merger and replaced with an option to purchase 168 Ordinary Shares of BIOX for $136.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This option, which provided for vesting over a period of four years, with 1/4th of the shares subject to the option vesting twelve months after the vesting commencement date of August 1, 2013, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, was assumed by BIOX in the Merger and replaced with an option to purchase 168 Ordinary Shares of BIOX for $136.36 per share."}],"balance_after":0,"derivative":{"exercise_price":12,"expiration_date":"2023-08-01","underlying":"Common Stock","underlying_shares":1911},"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2207479,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"disposition_to_issuer","acquired":false,"shares":560000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This option, which provided for vesting over a period of four years, with 1/4th of the shares subject to the option vesting twelve months after the vesting commencement date of May 3, 2018, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, was assumed by BIOX in the Merger and replaced with an option to purchase 49,280 Ordinary Shares of BIOX for $18.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This option, which provided for vesting over a period of four years, with 1/4th of the shares subject to the option vesting twelve months after the vesting commencement date of May 3, 2018, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, was assumed by BIOX in the Merger and replaced with an option to purchase 49,280 Ordinary Shares of BIOX for $18.75 per share."}],"balance_after":0,"derivative":{"exercise_price":1.65,"expiration_date":"2028-05-30","underlying":"Common Stock","underlying_shares":560000},"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2207478,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"disposition_to_issuer","acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This option, which provided for vesting in equal monthly installments over 48 months at the rate of 1/48th after the vesting commencement date of July 16, 2019, was assumed by BIOX in the Merger and replaced with an option to purchase 44,000 Ordinary Shares of BIOX for $16.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option, which provided for vesting in equal monthly installments over 48 months at the rate of 1/48th after the vesting commencement date of July 16, 2019, was assumed by BIOX in the Merger and replaced with an option to purchase 44,000 Ordinary Shares of BIOX for $16.36 per share."}],"balance_after":0,"derivative":{"exercise_price":1.44,"expiration_date":"2029-07-16","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2207477,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"disposition_to_issuer","acquired":false,"shares":157500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This option, which provided for vesting in equal monthly installments over three years, beginning on March 7, 2022, was cancelled in the Merger in exchange for 3,870 Ordinary Shares of BIOX having a market value of $9.44 per share on the effective date of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option, which provided for vesting in equal monthly installments over three years, beginning on March 7, 2022, was cancelled in the Merger in exchange for 3,870 Ordinary Shares of BIOX having a market value of $9.44 per share on the effective date of the Merger."}],"balance_after":0,"derivative":{"exercise_price":0.8,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2207476,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"exercise","acquired":false,"shares":195007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The settlement of restricted stock units is being reported as one award; however, a number of awards of restricted stock units, as reported in prior Forms 4, are being settled.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, details of the awards previously granted and settled as set forth in this footnote to this Form 4."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F5","text":"The settlement of restricted stock units is being reported as one award; however, a number of awards of restricted stock units, as reported in prior Forms 4, are being settled.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, details of the awards previously granted and settled as set forth in this footnote to this Form 4."},{"field":"shares","element":"transactionShares","label":"F7","text":"Any unvested restricted stock units vested completely immediately prior to the Merger, and the underlying shares were delivered to the Reporting Person immediately prior to the Merger in accordance with the terms of the grants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Any unvested restricted stock units vested completely immediately prior to the Merger, and the underlying shares were delivered to the Reporting Person immediately prior to the Merger in accordance with the terms of the grants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Any unvested restricted stock units vested completely immediately prior to the Merger, and the underlying shares were delivered to the Reporting Person immediately prior to the Merger in accordance with the terms of the grants."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The settlement of restricted stock units is being reported as one award; however, a number of awards of restricted stock units, as reported in prior Forms 4, are being settled.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, details of the awards previously granted and settled as set forth in this footnote to this Form 4."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Any unvested restricted stock units vested completely immediately prior to the Merger, and the underlying shares were delivered to the Reporting Person immediately prior to the Merger in accordance with the terms of the grants."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":195007},"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2207475,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"disposition_to_issuer","acquired":false,"shares":6442,"ownership":{"direct":false,"nature":"Held by Florence H. Marrone TOD Pamela G Marrone"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Disposed of pursuant to the Merger Agreement in exchange for 566 Ordinary Shares of BIOX having a market value of $9.44 per share on the effective date of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2207474,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"disposition_to_issuer","acquired":false,"shares":2394141,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to the Merger Agreement in exchange for 210,684 Ordinary Shares of BIOX having a market value of $9.44 per share on the effective date of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2207473,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-14T20:46:37.000Z","date":"2022-07-12","kind":"grant","acquired":true,"shares":195007,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Any unvested restricted stock units became vested and all restricted stock units were delivered to the Reporting Person, pursuant to the grant terms, immediately prior to the change of control transaction (the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 16, 2022, by and between Bioceres Crop Solutions Corp., BCS Merger Sub, Inc., and Issuer (the \"Merger Agreement\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The settlement of restricted stock units is being reported as one award; however, a number of awards of restricted stock units, as reported in prior Forms 4, are being settled. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, details of the awards previously granted and settled as set forth in this footnote to this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Any unvested restricted stock units became vested and all restricted stock units were delivered to the Reporting Person, pursuant to the grant terms, immediately prior to the change of control transaction (the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 16, 2022, by and between Bioceres Crop Solutions Corp., BCS Merger Sub, Inc., and Issuer (the \"Merger Agreement\")."}],"balance_after":2394141,"source":{"system":"sec-edgar","filing":"0001209191-22-042206","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042206/doc4.xml","form_type":"4"}},{"id":2210694,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-07-07T17:22:10.000Z","date":"2022-07-06","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of August 11, 2016, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months."}],"balance_after":3320,"derivative":{"exercise_price":0.8,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-041507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122041507/doc4.xml","form_type":"4"}},{"id":2210693,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-07T17:22:10.000Z","date":"2022-07-06","kind":"exercise","acquired":true,"shares":20000,"price":0.8,"value":16000.0,"ownership":{"direct":true},"balance_after":2199134,"source":{"system":"sec-edgar","filing":"0001209191-22-041507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122041507/doc4.xml","form_type":"4"}},{"id":2234062,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T17:20:14.000Z","date":"2022-06-09","kind":"sale","acquired":false,"shares":20492,"price":1.1771,"value":24121.1332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.15 to $1.21, inclusive. The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2179134,"source":{"system":"sec-edgar","filing":"0001209191-22-036400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122036400/doc4.xml","form_type":"4"}},{"id":2256657,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T18:50:51.000Z","date":"2022-05-24","kind":"sale","acquired":false,"shares":21009,"price":1.148,"value":24118.332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.10 to $1.19, inclusive. The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2199626,"source":{"system":"sec-edgar","filing":"0001209191-22-031981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122031981/doc4.xml","form_type":"4"}},{"id":2260125,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-05-23T20:33:12.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the following 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company."}],"balance_after":21000,"derivative":{"exercise_price":1.36,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001213900-22-028979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390022028979/ownership.xml","form_type":"4"}},{"id":2260124,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T20:33:12.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":11030,"price":1.36,"value":15000.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended March 31, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended March 31, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."}],"balance_after":14497,"source":{"system":"sec-edgar","filing":"0001213900-22-028979","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390022028979/ownership.xml","form_type":"4"}},{"id":2316550,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-28T17:40:43.000Z","date":"2022-03-24","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of August 11, 2016, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months."}],"balance_after":23320,"derivative":{"exercise_price":0.8,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-021343","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122021343/doc4.xml","form_type":"4"}},{"id":2316549,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-28T17:40:43.000Z","date":"2022-03-24","kind":"sale","acquired":false,"shares":22728,"price":1.11,"value":25228.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.10 to $1.13, inclusive. The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2220635,"source":{"system":"sec-edgar","filing":"0001209191-22-021343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122021343/doc4.xml","form_type":"4"}},{"id":2316548,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-28T17:40:43.000Z","date":"2022-03-24","kind":"exercise","acquired":true,"shares":20000,"price":0.8,"value":16000.0,"ownership":{"direct":true},"balance_after":2243363,"source":{"system":"sec-edgar","filing":"0001209191-22-021343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122021343/doc4.xml","form_type":"4"}},{"id":2426597,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-25T17:01:44.000Z","date":"2021-10-12","kind":"gift","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2223363,"source":{"system":"sec-edgar","filing":"0001209191-22-004825","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122004825/doc5.xml","form_type":"5"}},{"id":2433817,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-18T21:31:47.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":2467,"price":3.04,"value":7499.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended December 31, 2021. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended December 31, 2021. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3."}],"balance_after":3467,"source":{"system":"sec-edgar","filing":"0001213900-22-002418","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390022002418/ownership.xml","form_type":"4"}},{"id":2477279,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-10T23:39:32.000Z","date":"2021-12-10","kind":"purchase","acquired":true,"shares":1000,"price":4.1,"value":4100.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001213900-21-064771","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390021064771/ownership.xml","form_type":"4"}},{"id":2565604,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-09-17T16:29:42.000Z","date":"2021-09-15","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of August 11, 2016, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months."}],"balance_after":43320,"derivative":{"exercise_price":0.8,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-056635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121056635/doc4.xml","form_type":"4"}},{"id":2565603,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T16:29:42.000Z","date":"2021-09-15","kind":"exercise","acquired":true,"shares":30000,"price":0.8,"value":24000.0,"ownership":{"direct":true},"balance_after":2238363,"source":{"system":"sec-edgar","filing":"0001209191-21-056635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121056635/doc4.xml","form_type":"4"}},{"id":2590787,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T18:37:47.000Z","date":"2021-08-24","kind":"sale","acquired":false,"shares":24510,"price":1.02,"value":25000.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $1.00 to $1.03, inclusive.  The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2208363,"source":{"system":"sec-edgar","filing":"0001209191-21-053362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121053362/doc4.xml","form_type":"4"}},{"id":2608404,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T19:19:15.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":17858,"price":1.45,"value":25894.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.38 to $1.49, inclusive. The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2232873,"source":{"system":"sec-edgar","filing":"0001493152-21-019230","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000149315221019230/ownership.xml","form_type":"4"}},{"id":2613113,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy","published_at":"2021-08-05T20:19:29.000Z","date":"2021-08-04","kind":"grant","acquired":true,"shares":79000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated under the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated under the Exchange Act."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Options vest at the rate of 1/48th of such options ratably on a monthly basis over the following 48 months following the grant date, on the last day of each calendar month (beginning on August 31, 2021), subject to the holder's continued service to the Company."}],"balance_after":79000,"derivative":{"exercise_price":7.56,"expiration_date":"2031-08-04","underlying":"Common Stock","underlying_shares":79000},"source":{"system":"sec-edgar","filing":"0001213900-21-040520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390021040520/ownership.xml","form_type":"4"}},{"id":2622964,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-28T16:38:22.000Z","date":"2021-07-26","kind":"sale","acquired":false,"shares":17858,"price":1.4,"value":25001.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $1.38 to $1.43, inclusive.  The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares that are held jointly with spouse, which were previously reported separately."}],"balance_after":2250731,"source":{"system":"sec-edgar","filing":"0001209191-21-048435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121048435/doc4.xml","form_type":"4"}},{"id":2636029,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-12T18:33:14.000Z","date":"2021-07-09","kind":"sale","acquired":false,"shares":17007,"price":1.49,"value":25340.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $1.470 to $1.505, inclusive.  The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2215455,"source":{"system":"sec-edgar","filing":"0001209191-21-046335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121046335/doc4.xml","form_type":"4"}},{"id":2653351,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T16:56:09.000Z","date":"2021-06-24","kind":"sale","acquired":false,"shares":13662,"price":1.79,"value":24454.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $1.755 to $1.8300, inclusive.  The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2232462,"source":{"system":"sec-edgar","filing":"0001209191-21-043498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121043498/doc4.xml","form_type":"4"}},{"id":2671775,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T16:15:55.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":15061,"price":1.69,"value":25453.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $1.64 to $1.75, inclusive.  The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2246124,"source":{"system":"sec-edgar","filing":"0001209191-21-039822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121039822/doc4.xml","form_type":"4"}},{"id":2671774,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T16:15:55.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":16892,"price":1.41,"value":23817.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $1.41 to $1.49, inclusive.  The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2261185,"source":{"system":"sec-edgar","filing":"0001209191-21-039822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121039822/doc4.xml","form_type":"4"}},{"id":2710226,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-05-17T16:39:22.000Z","date":"2014-09-05","kind":"exercise","acquired":false,"shares":13807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of August 11, 2016, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months."}],"balance_after":0,"derivative":{"exercise_price":1.41,"expiration_date":"2021-12-15","underlying":"Common Stock","underlying_shares":13807},"source":{"system":"sec-edgar","filing":"0001209191-21-033177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121033177/doc4.xml","form_type":"4"}},{"id":2710225,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-17T16:39:22.000Z","date":"2021-05-14","kind":"exercise","acquired":true,"shares":13807,"price":1.41,"value":19467.87,"ownership":{"direct":true},"balance_after":2278077,"source":{"system":"sec-edgar","filing":"0001209191-21-033177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121033177/doc4.xml","form_type":"4"}},{"id":2876590,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-02-05T18:19:09.000Z","date":"2021-02-03","kind":"exercise","acquired":false,"shares":22058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vested with respect to 100% of the total shares subject to the grant on October 2, 2019, and the underlying shares were delivered to the reporting person on the first business day following the six-month anniversary of her retirement date in accordance with her separation agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vested with respect to 100% of the total shares subject to the grant on October 2, 2019, and the underlying shares were delivered to the reporting person on the first business day following the six-month anniversary of her retirement date in accordance with her separation agreement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22058},"source":{"system":"sec-edgar","filing":"0001209191-21-008271","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121008271/doc4.xml","form_type":"4"}},{"id":2876589,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-02-05T18:19:09.000Z","date":"2021-02-03","kind":"exercise","acquired":false,"shares":40704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested with respect to 100% of the total shares subject to the grant on March 25, 2018, and the underlying shares were delivered to the reporting person on the first business day following the six-month anniversary of her retirement date in accordance with her separation agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested with respect to 100% of the total shares subject to the grant on March 25, 2018, and the underlying shares were delivered to the reporting person on the first business day following the six-month anniversary of her retirement date in accordance with her separation agreement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":40704},"source":{"system":"sec-edgar","filing":"0001209191-21-008271","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121008271/doc4.xml","form_type":"4"}},{"id":2876588,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-02-05T18:19:09.000Z","date":"2021-02-03","kind":"exercise","acquired":false,"shares":25192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested with respect to 100% of the total shares subject to the grant on May 21, 2017, and the underlying shares were delivered to the reporting person on the first business day following the six-month anniversary of her retirement date in accordance with her separation agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested with respect to 100% of the total shares subject to the grant on May 21, 2017, and the underlying shares were delivered to the reporting person on the first business day following the six-month anniversary of her retirement date in accordance with her separation agreement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":25192},"source":{"system":"sec-edgar","filing":"0001209191-21-008271","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121008271/doc4.xml","form_type":"4"}},{"id":2876587,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-05T18:19:09.000Z","date":"2021-02-03","kind":"exercise","acquired":true,"shares":22058,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."}],"balance_after":2264270,"source":{"system":"sec-edgar","filing":"0001209191-21-008271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121008271/doc4.xml","form_type":"4"}},{"id":2876586,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-05T18:19:09.000Z","date":"2021-02-03","kind":"exercise","acquired":true,"shares":40704,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."}],"balance_after":2242212,"source":{"system":"sec-edgar","filing":"0001209191-21-008271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121008271/doc4.xml","form_type":"4"}},{"id":2876585,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-05T18:19:09.000Z","date":"2021-02-03","kind":"exercise","acquired":true,"shares":25192,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."}],"balance_after":2201508,"source":{"system":"sec-edgar","filing":"0001209191-21-008271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121008271/doc4.xml","form_type":"4"}},{"id":2950060,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Consultant"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-10T19:05:41.000Z","date":"2020-12-08","kind":"exercise","acquired":false,"shares":31863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of January 1, 2011, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months."}],"balance_after":0,"derivative":{"exercise_price":1.19,"expiration_date":"2021-01-24","underlying":"Common Stock","underlying_shares":31863},"source":{"system":"sec-edgar","filing":"0001209191-20-062794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120062794/doc4.xml","form_type":"4"}},{"id":2950059,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Consultant"}}],"security":"Common Stock","published_at":"2020-12-10T19:05:41.000Z","date":"2020-12-08","kind":"exercise","acquired":true,"shares":31863,"price":1.19,"value":37916.97,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities reported also reflects the acquisition of a total of 30,407 shares of the issuer's common stock pursuant to the issuer's employee stock purchase plan."}],"balance_after":2176316,"source":{"system":"sec-edgar","filing":"0001209191-20-062794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120062794/doc4.xml","form_type":"4"}},{"id":3067303,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Consultant"}}],"security":"Common Stock","published_at":"2020-08-05T19:17:51.000Z","date":"2020-08-04","kind":"grant","acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares subject to restricted stock units, which will vest in equal installments on each of the first three anniversaries of Dr. Marrone's retirement date of August 2, 2020, subject to her continuous service as a consultant through the applicable vesting dates."}],"balance_after":2114046,"source":{"system":"sec-edgar","filing":"0001209191-20-045298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120045298/doc4.xml","form_type":"4"}},{"id":3078706,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-21T19:15:55.000Z","date":"2020-07-15","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of August 11, 2016, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months."}],"balance_after":12500,"derivative":{"exercise_price":0.8,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-20-043244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120043244/doc4.xml","form_type":"4"}},{"id":3078705,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-07-21T19:15:55.000Z","date":"2020-07-15","kind":"exercise","acquired":true,"shares":12500,"price":0.8,"value":10000.0,"ownership":{"direct":true},"balance_after":864046,"source":{"system":"sec-edgar","filing":"0001209191-20-043244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120043244/doc4.xml","form_type":"4"}},{"id":3161049,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2020-05-05T17:11:48.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":40669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal installments on each of June 30, 2020, September 30, 2020 and December 31, 2020. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal installments on each of June 30, 2020, September 30, 2020 and December 31, 2020. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":40669,"derivative":{"underlying":"Common Stock","underlying_shares":40669},"source":{"system":"sec-edgar","filing":"0001209191-20-027204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120027204/doc4.xml","form_type":"4"}},{"id":3161048,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2020-05-05T17:11:48.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":154338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units fully vested on the grant date. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units fully vested on the grant date. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":154338,"derivative":{"underlying":"Common Stock","underlying_shares":154338},"source":{"system":"sec-edgar","filing":"0001209191-20-027204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120027204/doc4.xml","form_type":"4"}},{"id":3208742,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-16T20:27:52.000Z","date":"2020-03-13","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of August 11, 2016, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months."}],"balance_after":10000,"derivative":{"exercise_price":0.8,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-019425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120019425/doc4.xml","form_type":"4"}},{"id":3208741,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-03-16T20:27:52.000Z","date":"2020-03-13","kind":"exercise","acquired":true,"shares":10000,"price":0.8,"value":8000.0,"ownership":{"direct":true},"balance_after":851546,"source":{"system":"sec-edgar","filing":"0001209191-20-019425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120019425/doc4.xml","form_type":"4"}},{"id":3397278,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2019-10-04T18:28:29.000Z","date":"2019-10-02","kind":"grant","acquired":true,"shares":22058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on October 2, 2019. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on October 2, 2019. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":22058,"derivative":{"underlying":"Common Stock","underlying_shares":22058},"source":{"system":"sec-edgar","filing":"0001209191-19-052597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919119052597/doc4.xml","form_type":"4"}},{"id":3459149,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-18T16:51:18.000Z","date":"2019-07-16","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest over a period of four years, vesting in equal monthly installments over 48 months at the rate of 1/48th after the Vesting Commencement Date of July 16, 2019, subject to Optionee's continued employment."}],"balance_after":500000,"derivative":{"exercise_price":1.44,"expiration_date":"2029-07-16","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-19-042645","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919119042645/doc4.xml","form_type":"4"}},{"id":3564529,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2019-04-03T18:33:08.000Z","date":"2019-04-01","kind":"exercise","acquired":false,"shares":19092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 100% of the total shares subject to the option on the vesting commencement date of January 1, 2011."}],"balance_after":19092,"derivative":{"exercise_price":1.1926,"expiration_date":"2021-01-24","underlying":"Common Stock","underlying_shares":19092},"source":{"system":"sec-edgar","filing":"0001209191-19-023455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919119023455/doc4.xml","form_type":"4"}},{"id":3564528,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2019-04-03T18:33:08.000Z","date":"2019-04-01","kind":"exercise","acquired":false,"shares":4779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested with respect to 100% of the total shares subject to the option on the vesting commencement date of January 1, 2011."}],"balance_after":4779,"derivative":{"exercise_price":1.1926,"expiration_date":"2020-01-11","underlying":"Common Stock","underlying_shares":4779},"source":{"system":"sec-edgar","filing":"0001209191-19-023455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919119023455/doc4.xml","form_type":"4"}},{"id":3564527,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-04-03T18:33:08.000Z","date":"2019-04-01","kind":"exercise","acquired":true,"shares":19092,"price":1.1926,"value":22769.1192,"ownership":{"direct":true},"balance_after":841546,"source":{"system":"sec-edgar","filing":"0001209191-19-023455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919119023455/doc4.xml","form_type":"4"}},{"id":3564526,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-04-03T18:33:08.000Z","date":"2019-04-01","kind":"exercise","acquired":true,"shares":4779,"price":1.1926,"value":5699.4354,"ownership":{"direct":true},"balance_after":822454,"source":{"system":"sec-edgar","filing":"0001209191-19-023455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919119023455/doc4.xml","form_type":"4"}},{"id":3775655,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2018-11-02T17:44:08.000Z","date":"2018-10-31","kind":"exercise","acquired":false,"shares":9559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of January 1, 2009, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months."}],"balance_after":0,"derivative":{"exercise_price":1.1926,"expiration_date":"2019-01-28","underlying":"Common Stock","underlying_shares":9559},"source":{"system":"sec-edgar","filing":"0001209191-18-056978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919118056978/doc4.xml","form_type":"4"}},{"id":3775654,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-11-02T17:44:08.000Z","date":"2018-10-31","kind":"exercise","acquired":true,"shares":9559,"price":1.1926,"value":11400.0634,"ownership":{"direct":true},"balance_after":817675,"source":{"system":"sec-edgar","filing":"0001209191-18-056978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919118056978/doc4.xml","form_type":"4"}},{"id":3814211,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2018-09-17T17:55:09.000Z","date":"2018-09-13","kind":"exercise","acquired":false,"shares":47794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of November 1, 2008, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months."}],"balance_after":0,"derivative":{"exercise_price":1.19,"expiration_date":"2018-10-22","underlying":"Common Stock","underlying_shares":47794},"source":{"system":"sec-edgar","filing":"0001209191-18-051268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919118051268/doc4.xml","form_type":"4"}},{"id":3814210,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-17T17:55:09.000Z","date":"2018-09-13","kind":"tax_withholding","acquired":false,"shares":34987,"price":2.02,"value":70673.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents (i) 28,217 shares withheld to cover the exercise price for the purchase of common stock, and (ii) 6,770 shares withheld to satisfy Company tax withholding obligations. The difference between the number of options exercised (47,794) and the number of shares withheld to pay exercise price and taxes (34,987) results in a net settlement of 12,807 shares."}],"balance_after":808116,"source":{"system":"sec-edgar","filing":"0001209191-18-051268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919118051268/doc4.xml","form_type":"4"}},{"id":3814209,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-17T17:55:09.000Z","date":"2018-09-13","kind":"exercise","acquired":true,"shares":47794,"price":1.19,"value":56874.86,"ownership":{"direct":true},"balance_after":843103,"source":{"system":"sec-edgar","filing":"0001209191-18-051268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919118051268/doc4.xml","form_type":"4"}},{"id":3910611,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-01T18:53:43.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":560000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting twelve months after the Vesting Commencement Date of May 3, 2018, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, subject to Optionee's continued employment."}],"balance_after":560000,"derivative":{"exercise_price":1.65,"expiration_date":"2028-05-30","underlying":"Common Stock","underlying_shares":560000},"source":{"system":"sec-edgar","filing":"0001209191-18-034855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919118034855/doc4.xml","form_type":"4"}},{"id":3982965,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2018-03-26T19:20:48.000Z","date":"2018-03-25","kind":"grant","acquired":true,"shares":40704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on March 25, 2018. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on March 25, 2018. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":40704,"derivative":{"underlying":"Common Stock","underlying_shares":40704},"source":{"system":"sec-edgar","filing":"0001209191-18-021669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919118021669/doc4.xml","form_type":"4"}},{"id":4308072,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":109941,"kind":"person","name":"Marrone Pamela G","position":1,"cik":"0001582885","reported_name":"Marrone Pamela G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2017-05-23T17:57:12.000Z","date":"2017-05-21","kind":"grant","acquired":true,"shares":25192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested with respect to 100% of the total shares subject to the grant on the date of the grant. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested with respect to 100% of the total shares subject to the grant on the date of the grant. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":25192,"derivative":{"underlying":"Common Stock","underlying_shares":25192},"source":{"system":"sec-edgar","filing":"0001209191-17-034718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919117034718/doc4.xml","form_type":"4"}}]}